Bath & Body Works' (BBWI) Outperform Rating Reiterated at Telsey Advisory Group

Key Points

• Bath & Body Works' stock has been rated as "outperform" by Telsey Advisory Group with a price target of $38.00, suggesting a potential upside of 28.31% from its previous close.
• Currently, the stock has a consensus rating of "Moderate Buy", with fourteen analysts recommending a Buy rating and a consensus price target of $42.06.
• The company's recent quarterly earnings report showed $1.40 billion in revenue and $0.49 earnings per share, surpassing analysts' estimates.

Bath & Body Works (NYSE:BBWI - Get Free Report)'s stock had its "outperform" rating reiterated by analysts at Telsey Advisory Group in a research report issued on Thursday,Benzinga reports. They presently have a $38.00 price target on the stock. Telsey Advisory Group's price objective would indicate a potential upside of 22.36% from the stock's previous close.

Several other research firms also recently weighed in on BBWI. Morgan Stanley decreased their price objective on Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating for the company in a report on Tuesday, May 6th. Wells Fargo & Company boosted their price target on shares of Bath & Body Works from $40.00 to $44.00 and gave the company an "overweight" rating in a report on Wednesday, May 14th. The Goldman Sachs Group dropped their price objective on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating on the stock in a research note on Friday, May 30th. JPMorgan Chase & Co. lifted their price objective on shares of Bath & Body Works from $40.00 to $46.00 and gave the company an "overweight" rating in a report on Monday, July 28th. Finally, UBS Group upped their target price on Bath & Body Works from $32.00 to $36.00 and gave the stock a "neutral" rating in a report on Tuesday, May 20th. Fourteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, Bath & Body Works currently has an average rating of "Moderate Buy" and an average price target of $42.06.

Bath & Body Works Trading Up 5.6%

Shares of Bath & Body Works stock traded up $1.6350 on Thursday, hitting $31.0550. 4,792,107 shares of the company traded hands, compared to its average volume of 4,610,963. The company has a market cap of $6.57 billion, a PE ratio of 8.28, a PEG ratio of 1.04 and a beta of 1.54. The stock's 50 day moving average price is $30.30 and its 200-day moving average price is $30.97. Bath & Body Works has a 52 week low of $24.94 and a 52 week high of $41.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its earnings results on Thursday, May 29th. The company reported $0.49 earnings per share for the quarter, beating analysts' consensus estimates of $0.47 by $0.02. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%.The business had revenue of $1.40 billion during the quarter, compared to analyst estimates of $1.42 billion. During the same period in the previous year, the company posted $0.38 EPS. Bath & Body Works's revenue was up 2.9% on a year-over-year basis. Bath & Body Works has set its Q2 2025 guidance at 0.330-0.380 EPS. As a group, research analysts anticipate that Bath & Body Works will post 3.3 EPS for the current fiscal year.

Institutional Investors Weigh In On Bath & Body Works

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BBWI. Parkside Financial Bank & Trust boosted its holdings in Bath & Body Works by 24.6% in the second quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company's stock worth $55,000 after acquiring an additional 364 shares in the last quarter. Northwest Bank & Trust Co raised its position in shares of Bath & Body Works by 2.9% in the 4th quarter. Northwest Bank & Trust Co now owns 14,700 shares of the company's stock valued at $533,000 after purchasing an additional 419 shares during the last quarter. Parallel Advisors LLC boosted its stake in Bath & Body Works by 63.3% in the 2nd quarter. Parallel Advisors LLC now owns 1,241 shares of the company's stock worth $37,000 after purchasing an additional 481 shares in the last quarter. Blue Trust Inc. grew its position in Bath & Body Works by 15.5% during the 1st quarter. Blue Trust Inc. now owns 4,184 shares of the company's stock worth $127,000 after purchasing an additional 560 shares during the last quarter. Finally, UMB Bank n.a. grew its position in Bath & Body Works by 65.9% during the 1st quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock worth $46,000 after purchasing an additional 596 shares during the last quarter. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.